Inhibrx Biosciences, Inc. Financial Flexibility Index
Inhibrx Biosciences, Inc. financial flexibility index. Inhibrx Biosciences, Inc. (INBX) has a Financial Flexibility Index of -0.19x as of March 2026. Free cash flow of $-38.03 Million (operating CF $-38.03 Million minus capex $0.00) represents 0% of total liabilities ($205.00 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Inhibrx Biosciences, Inc. (2016–2025)
Financial flexibility index of Inhibrx Biosciences, Inc. from 2016 to 2025. Historical Financial Flexibility Index trend for Inhibrx Biosciences, Inc. across 10 annual periods. Check Inhibrx Biosciences, Inc. (INBX) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Inhibrx Biosciences, Inc. Financial Flexibility Index by Year (2016–2025)
Inhibrx Biosciences, Inc. financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Inhibrx Biosciences, Inc.. For the full cash flow conversion analysis, see Inhibrx Biosciences, Inc. cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.94x | $-129.76 Million | $-129.79 Million | $138.49 Million | ▲ +77.0% |
| 2024 | -4.07x | $-191.81 Million | $-194.41 Million | $47.18 Million | ▼ -469.5% |
| 2023 | -0.71x | $-188.72 Million | $-193.31 Million | $264.39 Million | ▼ -45.0% |
| 2022 | -0.49x | $-114.61 Million | $-115.30 Million | $232.82 Million | ▲ +39.2% |
| 2021 | -0.81x | $-79.46 Million | $-80.32 Million | $98.07 Million | ▼ -18.7% |
| 2020 | -0.68x | $-46.60 Million | $-47.97 Million | $68.27 Million | ▼ -170.8% |
| 2019 | -0.25x | $-30.27 Million | $-32.08 Million | $120.06 Million | ▲ +21.3% |
| 2018 | -0.32x | $-21.66 Million | $-23.09 Million | $67.63 Million | ▲ +27.0% |
| 2017 | -0.44x | $-17.41 Million | $-18.75 Million | $39.67 Million | ▲ +50.9% |
| 2016 | -0.89x | $-17.89 Million | $-18.11 Million | $20.03 Million | — |